{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:14:38Z","timestamp":1771931678075,"version":"3.50.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Primary percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI) can carry high stakes, as major adverse cardiac events (MACE) like no-reflow, malignant arrhythmias, and cardiogenic shock can disrupt the procedure and worsen outcomes. In light of these challenges, this study aimed to develop a nomogram prediction model to rapidly assess MACE risk during PCI in STEMI patients, aiding in timely risk stratification prior to surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study included 1050 STEMI patients who underwent primary PCI between December 30, 2016, and May 13, 2023. Clinical data were collected from emergency admissions. Multiple logistic regression models were used to analyze the independent risk factors for intraoperative MACE. A nomogram was then constructed and validated via bootstrap resampling. Model performance was assessed using an ROC curve for discrimination and a calibration curve for accuracy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The incidence of intraoperative MACE in STEMI patients was 38.3%. Independent risk factors for intraoperative MACE included Killip classification, ST-segment elevation in \u22653 leads, white blood cell count, lymphocyte count, and heart rate. A simple and rapidly obtainable nomogram, developed to predict MACE during PCI, showed good differentiation, with an area under the ROC curve of 0.785 (95% CI: 0.755\u20130.814). Decision curve analysis indicated good fit, calibration, and positive net benefits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A nomogram was developed to rapidly predict intraoperative MACE risk during PCI in STEMI patients before surgery. By enabling early identification of high-risk individuals, this model enhances clinical decision-making, potentially improving patient outcomes and procedural efficiency.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1691709","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:15:16Z","timestamp":1770880516000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A nomogram for predicting intraoperative risk during primary percutaneous coronary intervention based on rapidly obtained data from ST-segment elevation myocardial infarction patients"],"prefix":"10.3389","volume":"13","author":[{"given":"Yutian","family":"Wang","sequence":"first","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Department of Cardiology, Nanfang Hospital, Southern Medical University","place":["Guangzhou, Guangdong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Department of Cardiology, Nanfang Hospital, Southern Medical University","place":["Guangzhou, Guangdong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yejia","family":"Chen","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Department of Cardiology, Nanfang Hospital, Southern Medical University","place":["Guangzhou, Guangdong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Nanchang University","place":["Nanchang, Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Public Health, Southern Medical University","place":["Guangzhou, Guangdong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaocong","family":"Liu","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Department of Cardiology, Nanfang Hospital, Southern Medical University","place":["Guangzhou, Guangdong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaile","family":"Zhao","sequence":"additional","affiliation":[{"name":"The Xiangya School of Medicine, Central South University","place":["Changsha, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoran","family":"Shou","sequence":"additional","affiliation":[{"name":"The Xiangya School of Medicine, Central South University","place":["Changsha, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Xiangdong Hospital Hunan Normal University","place":["Liling City, Hunan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiancheng","family":"Xiu","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Department of Cardiology, Nanfang Hospital, Southern Medical University","place":["Guangzhou, Guangdong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Xiangdong Hospital Hunan Normal University","place":["Liling City, Hunan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1161\/CIRCULATIONAHA.119.041297","article-title":"Resource and infrastructure-appropriate management of ST-segment elevation myocardial infarction in low- and middle-income countries","volume":"141","author":"Chandrashekhar","year":"2020","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1253\/circj.CJ-16-0183","article-title":"Clinical impact of ventricular tachycardia and\/or fibrillation during the acute phase of acute myocardial infarction on in-hospital and 5-year mortality rates in the percutaneous coronary intervention era","volume":"80","author":"Masuda","year":"2016","journal-title":"Circ J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.jcin.2022.01.283","article-title":"Percutaneous coronary intervention volume and cardiac surgery availability effect on acute coronary syndrome-related cardiogenic shock","volume":"15","author":"Noaman","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1093\/eurheartj\/ehx414","article-title":"Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials","volume":"38","author":"de Waha","year":"2017","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCULATIONAHA.111.023838","article-title":"Epidemiology and genetics of sudden cardiac death","volume":"125","author":"Deo","year":"2012","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1161\/01.CIR.93.2.223","article-title":"Clinical implications of the \u2018no reflow\u2019 phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction","volume":"93","author":"Ito","year":"1996","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1001\/jama.2009.600","article-title":"Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention","volume":"301","author":"Mehta","year":"2009","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jacc.2009.03.054","article-title":"Myocardial no-reflow in humans","volume":"54","author":"Niccoli","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1067\/mhj.2003.36","article-title":"No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention","volume":"145","author":"Resnic","year":"2003","journal-title":"Am Heart J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1001\/jama.2021.18323","article-title":"Cardiogenic shock after acute myocardial infarction a review","volume":"326","author":"Samsky","year":"2021","journal-title":"JAMA"},{"key":"B11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/MCA.0000000000000726","article-title":"Predictors and outcomes of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"30","author":"Tasar","year":"2019","journal-title":"Coron Artery Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000346386","article-title":"Development and validation of a clinical risk score predicting the no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction","volume":"124","author":"Wang","year":"2013","journal-title":"Cardiology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3390\/ijerph19041997","article-title":"Development of a clinical risk score for prediction of life-threatening arrhythmia events in patients with ST elevated acute coronary syndrome after primary percutaneous coronary intervention","volume":"19","author":"Wongthida","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B14","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: a method for prognostication and therapeutic decision making","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1001\/jama.291.22.2727","article-title":"A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry","volume":"291","author":"Eagle","year":"2004","journal-title":"JAMA"},{"key":"B16","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1161\/CIRCRESAHA.116.310527","article-title":"How common is residual inflammatory risk?","volume":"120","author":"Ridker","year":"2017","journal-title":"Circ Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.jacc.2015.12.048","article-title":"Leukocytes link local and systemic inflammation in ischemic cardiovascular disease: an expanded \u201ccardiovascular Continuum\u201d","volume":"67","author":"Libby","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/cvr\/cvz336","article-title":"Cardiac monocytes and macrophages after myocardial infarction","volume":"116","author":"Peet","year":"2020","journal-title":"Cardiovasc Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12959-022-00384-0","article-title":"Complement C5a induces the generation of neutrophil extracellular traps by inhibiting mitochondrial STAT3 to promote the development of arterial thrombosis","volume":"20","author":"Chen","year":"2022","journal-title":"Thromb J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1080\/14017431.2020.1783457","article-title":"The combination of neutrophil-to-lymphocyte ratio and platelet correlation parameters in predicting the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction","volume":"54","author":"Zhang","year":"2020","journal-title":"Scand Cardiovasc J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/00015385.2021.1884786","article-title":"Systemic immune-inflammation index predicts no-reflow phenomenon after primary percutaneous coronary intervention","volume":"77","author":"Esenboga","year":"2022","journal-title":"Acta Cardiol"},{"key":"B22","first-page":"406","article-title":"The role of the initial 12-lead ECG in risk stratification of patients with acute coronary syndrome","volume":"102","author":"Schweitzer","year":"2001","journal-title":"Bratisl Lek Listy"},{"key":"B23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ajem.2010.10.011","article-title":"Killip classification in patients with acute coronary syndrome: insight from a multicenter registry","volume":"30","author":"El-Menyar","year":"2012","journal-title":"Am J Emerg Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e12209","DOI":"10.7759\/cureus.12209","article-title":"Risk assessment of patients after ST-segment elevation myocardial infarction by Killip classification: an institutional experience","volume":"12","author":"Hashmi","year":"2020","journal-title":"Cureus"},{"key":"B25","doi-asserted-by":"publisher","first-page":"966299","DOI":"10.3389\/fcvm.2022.966299","article-title":"A nomogram risk prediction model for no-reflow after primary percutaneous coronary intervention based on rapidly accessible patient data among patients with ST-segment elevation myocardial infarction and its relationship with prognosis","volume":"9","author":"Liu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0735-1097(93)90044-2","article-title":"Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy","volume":"22","author":"Van de Werf","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1093\/eurheartj\/ehaa733","article-title":"Metoprolol exerts a non-class effect against ischaemia-reperfusion injury by abrogating exacerbated inflammation","volume":"41","author":"Clemente-Morag\u00f3n","year":"2020","journal-title":"Eur Heart J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ccl.2023.03.013","article-title":"Sinus node dysfunction","volume":"41","author":"Sathnur","year":"2023","journal-title":"Cardiol Clin"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.2174\/1381612824666180702112536","article-title":"Coronary no-reflow phenomenon in clinical practice","volume":"24","author":"Scarpone","year":"2018","journal-title":"Curr Pharm Des"},{"key":"B30","doi-asserted-by":"publisher","first-page":"11248","DOI":"10.12998\/wjcc.v9.i36.11248","article-title":"Sodium nitroprusside injection immediately before balloon inflation during percutaneous coronary intervention","volume":"9","author":"Yu","year":"2021","journal-title":"World J Clin Cases"},{"key":"B31","doi-asserted-by":"publisher","first-page":"913403","DOI":"10.3389\/fmed.2022.913403","article-title":"Veno-arterial extracorporeal membrane oxygenation in elective high-risk percutaneous coronary interventions","volume":"9","author":"Bai","year":"2022","journal-title":"Front Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e1227","DOI":"10.4244\/EIJ-D-20-01076","article-title":"Veno-arterial extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock: rationale and design of the randomised, multicentre, open-label EURO SHOCK trial","volume":"16","author":"Banning","year":"2021","journal-title":"EuroIntervention"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1691709\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:27:37Z","timestamp":1771928857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1691709\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":32,"alternative-id":["10.3389\/fcvm.2026.1691709"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1691709","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"article-number":"1691709"}}